Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (341-350 of 594) with videos related to

Pageof 60
Sort By:
Diabetes|March 16, 2007
PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetesTakafumi Nakamachi, Takashi Nomiyama, Florence Gizard, et al.
FEBS Letters|October 22, 2013
PPARalpha regulates the production of serum Vanin-1 by liverSamuel Rommelaere, Virginie Millet, Thomas Gensollen, et al.
Journal of Hepatology|May 24, 2023
NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation studyStephen A Harrison, Vlad Ratziu, Jeremy Magnanensi, et al.
Circulation Research|November 29, 2002
PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4Ulrich Kintscher, Christopher Lyon, Shu Wakino, et al.
Journal of Hepatology|February 10, 2006
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesRonit Shiri-Sverdlov, Kristiaan Wouters, Patrick J van Gorp, et al.
The Journal of Biological Chemistry|September 21, 2010
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathwaysMouaadh Abdelkarim, Sandrine Caron, Christian Duhem, et al.
Atherosclerosis|January 2, 2007
Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statinsChristophe Zawadzki, Sophie Susen, Florence Richard, et al.
The Journal of Investigative Dermatology|January 8, 2004
Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skinMajken Westergaard, Jeanette Henningsen, Claus Johansen, et al.
Diabetes|March 30, 2004
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient miceNicholas M Morton, Janice M Paterson, Hiroaki Masuzaki, et al.
Plos One|June 14, 2013
The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptorsSébastien Flajollet, Christophe Rachez, Maheul Ploton, et al.
Pageof 60

Showing results (341-350 of 594) with videos related to

Sort By:
Pageof 60
Diabetes|March 16, 2007
PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetesTakafumi Nakamachi, Takashi Nomiyama, Florence Gizard, et al.
FEBS Letters|October 22, 2013
PPARalpha regulates the production of serum Vanin-1 by liverSamuel Rommelaere, Virginie Millet, Thomas Gensollen, et al.
Journal of Hepatology|May 24, 2023
NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation studyStephen A Harrison, Vlad Ratziu, Jeremy Magnanensi, et al.
Circulation Research|November 29, 2002
PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4Ulrich Kintscher, Christopher Lyon, Shu Wakino, et al.
Journal of Hepatology|February 10, 2006
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesRonit Shiri-Sverdlov, Kristiaan Wouters, Patrick J van Gorp, et al.
The Journal of Biological Chemistry|September 21, 2010
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathwaysMouaadh Abdelkarim, Sandrine Caron, Christian Duhem, et al.
Atherosclerosis|January 2, 2007
Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statinsChristophe Zawadzki, Sophie Susen, Florence Richard, et al.
The Journal of Investigative Dermatology|January 8, 2004
Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skinMajken Westergaard, Jeanette Henningsen, Claus Johansen, et al.
Diabetes|March 30, 2004
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient miceNicholas M Morton, Janice M Paterson, Hiroaki Masuzaki, et al.
Plos One|June 14, 2013
The elongation complex components BRD4 and MLLT3/AF9 are transcriptional coactivators of nuclear retinoid receptorsSébastien Flajollet, Christophe Rachez, Maheul Ploton, et al.
Pageof 60